California Pressures Bristol-Myers Squibb on Cost of AIDS Drug
August 3, 2010
In the last decade, the number of clients seeking help from California's AIDS Drug Assistance Program has grown by 60 percent. Concurrently, ADAP's spending on drugs has ballooned by almost 200 percent, from $302 for each antiretroviral prescription a decade ago to $583 per prescription today. Now state officials are calling on one drug company in particular, Bristol-Myers Squibb (BMS), to help control drug costs.
Last month, Controller John Chiang wrote BMS asking it "to step up and join the other pharmaceutical companies that have found ways to reduce the cost of drugs to California."
07.29.2010; Bobby Caina Calvan; Phillip Reese
A Slice of Atazanavir, but Hold the Ritonavir: Switch to Unboosted Dose Still Effective After 120 Weeks, With Good Lipid Findings
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)